HB
Haku Bio, Inc.
SEC filingBiotechnology · Arlington, MA
Amount raised$1.3Msold at filing
Total offering$2.5M$1.2M still open
Investors in the raise5count reported to the SEC
FiledJun 10, 2026first sale May 22, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Bill LundbergDirector
Sandy MongExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.